title: Enhancement of alloimmunization: a potential hazard of GM-CSF treatment in patients with severe aplastic anemia?
authors.forename: M
authors.initials: M
authors.lastname: Kuentz
authors.forename: P
authors.initials: P
authors.lastname: Bierling
authors.forename: F
authors.initials: F
authors.lastname: Norolle
authors.forename: C
authors.initials: C
authors.lastname: Cordonnier
authors.forename: H
authors.initials: H
authors.lastname: Rochant
authors.forename: J P
authors.initials: JP
authors.lastname: Vernant
mesh_terms: D000328:Adult; D000741:Anemia, Aplastic / Q000628:therapy*; D001787:Blood Group Incompatibility / Q000209:etiology*; D003115:Colony-Stimulating Factors / Q000009:adverse effects*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000009:adverse effects*; D006801:Humans; D008297:Male; D065227:Transfusion Reaction
chemical_list: D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016178:Granulocyte-Macrophage Colony-Stimulating Factor